Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Antivir Ther. 2010;15(3 Pt B):487–491. doi: 10.3851/IMP1553

Figure 1. Frequency of lamivudine-resistant HBV in 53 HIV-HBV co-infected subjects with HBV viremia.

Figure 1

The frequency of both the single/dual (rtM204V/I ± rtL180M) and triple mutants (rtL173T+ rtL180M+ rtM204V/I) increase with duration of lamivudine therapy.